Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Knowing what to include in your retirement budget is vital. This guide helps you identify essential expenses for a comfortable retirement.
16,877 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
On June 12, the stock market today, june delivered a space-focused pivot as AST SpaceMobile fell after gains and Spac...
A stock rising 58% this year can signal momentum or a looming reversal. This guide helps you evaluate whether it rema...
A new wave in energy investing centers on nuclear power having moment. This article identifies three stocks that stan...
This satellite data stock has pulled back after a scorching rally. In this guide, you’ll learn what powers its busine...
Ripple's XRP Ledger is moving toward an on-chain lending layer. This article explains how the ledger's 'missing layer...
Micron Technology has sprinted to the high end of a price landscape after surging 814% year. As investors weigh the n...
AI is driving a surge in data centers, but that surge may bring debt challenges. This guide breaks down how to read t...
AMD is positioning itself as a robust player across consumer, data center, and AI markets. This article breaks down w...
Novartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...